PLUS1
Cynata Therapeutics Financial Data
| Company name: | Cynata Therapeutics Ltd | Status: | Active |
| End of fiscal year: | June 29 2018 | ISIN | AU000000CYP7 |
| Year established: | 2003 | Company sector name: | Healthcare |
| Trading currency: | AUD | Industry name: | Biotechnology |
| Place of incorporation: | Australia (AU) | Industry group name | Biotechnology |
| Doing business in: | Australia (AU) | Address | 62 Lygon Street Level 3, Carlton, 3053 |
| Tel.: | +61 398245254 | City/Country: | Melbourne, Australia |
| Fax: | +61 398227735 | Web address: | http://www.cynata.com |
| Company description: | Cynata Therapeutics Ltd is an Australian stem cell and regenerative medicine company, that is developing a therapeutic stem cell platform technology, branded has Cymerus. |
| Price | Price change [%] | Bid | Offer | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 0.60 | -0.005[-0.83%] | 0.595 | 0.61 | 0.615 | 0.615 | 0.60 | 172,416 |
| Market Cap. [m] | Shares In Issue [m] | Beta | EPS | DPS | PE Ratio | Yield | 52-Wks-Range |
| 54.818415355 | 101.885053 | 0.02 | -0.05 | - | -12.00 | - | 0.57 - 1.15 |
CYP KEY FIGURES (at previous day's close) | |
|---|---|
Yesterday's Close | 0.61 |
PE Ratio | -12.00 |
Market Capitalisation | 54.82M |
Latest Shares Outstanding | 101.89M |
Earnings pS (EPS) | -0.05 |
Dividend pS (DPS) | - |
Dividend Yield | - |
Sales per Employee | - |
Effective Tax Rate | - |
Foreign Sales | - |
Domestic Sales | - |
Selling, General & Adm/tive (SG... | - |
Research & Devlopment (R&D) as ... | - |
Gross Profit Margin | - |
EBITDA Margin | - |
Pre-Tax Profit Margin | - |
Assets Turnover | - |
Return on Assets (ROA) | -0.30% |
Return on Equity (ROE) | -0.31% |
Return on Capital Invested (ROC... | -0.32% |
Current Ratio | 16.89 |
Leverage Ratio (Assets/Equity) | 1.05% |
Interest Cover | - |
Total Debt/Equity (Gearing Rati... | - |
LT Debt/Total Capital | - |
Working Capital pS | 0.17 |
Cash pS | 0.13 |
Book-Value pS | 0.14 |
Tangible Book-Value pS | - |
Cash Flow pS | - |
Free Cash Flow pS | -0.04 |
Spread | 0.02 |
Gross gearing | 0.00% |
Net Debt | -12.21M |
CYP Balance Sheet Chart (June 29 2018) | ||
|---|---|---|
 | ||
| Period | High | Low |
|---|---|---|
| 1 Week | 0.64 | 0.59 |
| 1 Month | 0.675 | 0.57 |
| 3 Months | 0.73 | 0.57 |
| 6 Months | 0.93 | 0.57 |
| 1 Year | 1.145 | 0.57 |
| 3 Years | 1.87 | 0.57 |
| 5 Years | 1.87 | 0.26 |
Share price performance previous 3 years |
|---|
Share price performance intraday |
|---|
| Period | Open | Open Avg. | VWAP | Min Vol | Max Vol | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|---|
| 1 Week | 0.605 | 0.603 | 0.606139 | 60,314 | 419,598 | 221,032 | -0.005 | -0.83% |
| 1 Month | 0.66 | 0.611667 | 0.610401 | 41,800 | 538,074 | 215,580 | -0.06 | -9.09% |
| 3 Months | 0.685 | 0.644636 | 0.649889 | 41,800 | 762,912 | 245,758 | -0.085 | -12.41% |
| 6 Months | 0.845 | 0.711 | 0.710091 | 5,554 | 1,262,437 | 251,438 | -0.245 | -28.99% |
| 1 Year | 0.75 | 0.730031 | 0.736514 | 5,554 | 2,264,686 | 299,808 | -0.15 | -20.0% |
| 3 Years | 1.40 | 1.071 | 0.956451 | 1,396 | 2,264,686 | 176,807 | -0.80 | -57.14% |
| 5 Years | 0.36 | 0.882001 | 0.815602 | 1,396 | 2,264,686 | 185,342 | 0.24 | 66.67% |
CYP Growth Ratios (June 29 2018) | ||||
|---|---|---|---|---|
| 1 year | 3 years | 5 years | 10 years | |
Diluted EPS growth | - | - | - | - |
Diluted continuous EPS growth | - | - | - | - |
Dividend growth | - | - | - | - |
Equity per share growth | 0.05 | 0.07 | 0.20 | -0.13 |
Revenue growth | - | - | - | - |
Operating income growth | - | - | - | - |
Net income growth | - | - | - | - |
Net income cont growth | - | - | - | - |
CFO growth | - | - | - | - |
FCF growth | - | - | - | - |
Operating revenue growth | - | - | - | - |
CYP Income Statement June 29 2018 (AUD) | |
|---|---|
Operating Expenses | 6.131021 |
Selling,General and Administr... | 2.454224 |
General and Administrative Ex... | 2.454224 |
Salary and Benefit | 1.334319 |
OtherGandA | 1.119905 |
Depreciation,Amortization and... | 0.279965 |
Depreciation and Amortization | 0.279965 |
Amortization | 0.279965 |
Amortization of Intangibles | 0.279965 |
Other Operating Expenses | 3.396832 |
Operating Income | -6.131021 |
Interest Income/Expense,Net-N... | 0.142925 |
Interest Income-Non Operating | 0.142925 |
Other Income/Expense,Net | 1.421962 |
Other Non-Operating Income/Ex... | 1.421962 |
Pretax Income | -4.566134 |
Provision for Income Tax | 0.00 |
Net Income Available to Commo... | -4.566134 |
Net Income | -4.566134 |
Net Income Including Noncontr... | -4.566134 |
Net Income from Continuing Op... | -4.566134 |
Basic EPS | -0.05 |
Basic EPS from Continuing Ope... | -0.05 |
Basic EPS from Discontinued O... | 0.00 |
Diluted EPS | -0.05 |
Diluted EPS from Continuing O... | -0.05 |
Diluted EPS from Discontinued... | 0.00 |
Basic Weighted Average Shares... | 90.608951 |
Diluted Weighted Average Shar... | 90.608951 |
Net Income from Continuing an... | -4.566134 |
Normalized Income | -4.566134 |
Basic EPS,Continuing and Disc... | -0.05 |
Diluted EPS,Continuing and Di... | -0.05 |
Interest and Dividend Income | 0.142925 |
Net Interest Income | 0.142925 |
Earning Before Interest and T... | -6.131021 |
Earning Before Interest Tax D... | -5.851056 |
Depreciation,Reconciled | 0.279965 |
Net Income from Continuing Op... | -4.566134 |
Normalized Basic EPS | -0.05 |
Normalized Diluted EPS | -0.05 |
NormalizedEBITDA | -5.851056 |
Tax rate for calculations | 0.00 |
CYP Efficency Ratios (June 29 2018) | |
|---|---|
Days in sales | - |
Days in inventory | - |
Days in payment | - |
Cash conversion cycle | - |
Receivable turnover | - |
Inventory turnover | - |
Payable turnover | - |
Fixed assets turnover | - |
Assets turnover | - |
ROE | -0.31 |
ROA | -0.30 |
ROIC | -0.32 |
FCF sales ratio | - |
FCF net income ratio | - |
Capital expenditure sales ratio | - |
CYP Financial Health Ratios (June 29 2018) | |
|---|---|
Current ratio | 16.89 |
Quick ratio | 16.43 |
Debt total capital ratio | - |
Debt equity ratio | - |
Financial leverage | 1.05 |
Total debt to equity | - |
CYP Avearge Growth Ratios Over 5 Years (June 29 2018) | |
|---|---|
Growth ann capital spending | - |
Growth ann gross profit | - |
Avg gross margin | - |
Avg post tax margin | - |
Avg pre tax marginr | - |
Avg net profit | - |
Avg ret commonr | -0.44 |
Avg ret assets | -0.43 |
Avg ret invested capital | -0.45 |
CYP Profitability Ratios (June 29 2018) | |
|---|---|
Gross margin | - |
Operating margin | - |
EBT margin | - |
Tax rate | - |
Net margin | - |
Sales per employee | - |
EBIT margin | - |
EBITDA margin | - |
Normalized net profit margin | - |
Interest coverage | - |
Inc per employee tot ops | - |
CYP Valuation Ratios (June 28 2018) | |
|---|---|
Sales per share | - |
Growth ann sales per share 5 ye... | - |
Book value per share | 0.13 |
CF per share | -0.05 |
Price to EPS | - |
Ratio PE 5 year high | - |
Ratio PE 5 year low | - |
Price to book | 10.59 |
Price to sales | - |
Price to cash flow | - |
Price to free cash flow | - |
Div rate | - |
Dividend yield | - |
Div payout tot ops | - |
Div payout 5 year | - |
Payout ratio | 0.00 |
Sustainable growth rate | -0.48 |
Cash return | - |
CYP Balance Sheet June 29 2018 (AUD) | |
|---|---|
Total Assets | 16.133008 |
Current Assets | 12.599816 |
Cash,Cash Equivalents,and Sho... | 12.20604 |
Cash and Cash Equivalents | 12.20604 |
Cash | 12.20604 |
Receivables | 0.056256 |
Other Receivables | 0.056256 |
Prepaid Assets and Others | 0.33752 |
Total Non-Current Assets | 3.533192 |
Goodwill and Other Intangible... | 3.533192 |
Other Intangible Assets | 3.533192 |
Total Liabilities | 0.746146 |
Current Liabilities | 0.746146 |
Payables and Accrued Expenses | 0.725395 |
Payables | 0.725395 |
Accounts Payable | 0.29908 |
Other Payable | 0.426315 |
Pension and Other Post-Retire... | 0.020751 |
Total Non-Current Liabilities | 0.00 |
Total Equity | 15.386862 |
Stockholder's Equity | 15.386862 |
Capital Stock | 44.191746 |
Common Stock | 44.191746 |
Retained Earnings | -33.05021 |
Accumulated Gains/ Losses Not... | 4.245326 |
Foreign Currency Translation ... | 4,724.00 |
Other Equity Adjustments | 4.240602 |
Total Capitalization | 15.386862 |
Common Stock Equity | 15.386862 |
Net Tangible Assets | 11.85367 |
Working Capital | 11.85367 |
Invested Capital | 15.386862 |
Tangible Book Value | 11.85367 |
Ordinary Shares Number | 95.066251 |
TotalLiabilitiesAsReported | 0.746146 |
TotalEquityAsReported | 15.386862 |
CYP Cash Flow June 29 2018 (AUD) | |
|---|---|
Classes of Cash Receipts from... | 1.375135 |
Other Cash Receipts from Oper... | 1.375135 |
Classes of Cash Payments | -5.598394 |
Payments to Suppliers for Goo... | -2.583941 |
Other Cash Payments from Oper... | -3.014453 |
Interest Received, Direct | 0.161343 |
Cash Flow from Financing Acti... | 5.858413 |
Cash Flow from Continuing Fin... | 5.858413 |
Issuance/Payments of Common S... | 5.858413 |
Proceeds or Issuance of Commo... | 5.988441 |
Payments for Common Stock | -0.130028 |
Cash and Cash Equivalents,End... | 12.20604 |
Change in Cash | 1.796497 |
Effect of Exchange Rate Chang... | 0.059779 |
Cash and Cash Equivalents,Beg... | 10.349764 |
Issuance of Capital Stock | 5.988441 |
Repurchase of Capital Stock | -0.130028 |
Free Cash Flow | -4.061916 |
ChangeinCashSupplementalAsRep... | 1.796497 |
